These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 15113844)

  • 1. Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.
    Misumi S; Morikawa Y; Tomonaga M; Ohkuma K; Takamune N; Shoji S
    J Biochem; 2004 Mar; 135(3):447-53. PubMed ID: 15113844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.
    Accola MA; Strack B; Göttlinger HG
    J Virol; 2000 Jun; 74(12):5395-402. PubMed ID: 10823843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion mutagenesis within the dimerization initiation site of human immunodeficiency virus type 1 results in delayed processing of the p2 peptide from precursor proteins.
    Liang C; Rong L; Cherry E; Kleiman L; Laughrea M; Wainberg MA
    J Virol; 1999 Jul; 73(7):6147-51. PubMed ID: 10364374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly.
    Accola MA; Höglund S; Göttlinger HG
    J Virol; 1998 Mar; 72(3):2072-8. PubMed ID: 9499062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
    Wu X; Liu H; Xiao H; Kappes JC
    Virology; 1996 May; 219(1):307-13. PubMed ID: 8623547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HIV-1 replication by a peptide dimerization inhibitor of HIV-1 protease.
    Davis DA; Brown CA; Singer KE; Wang V; Kaufman J; Stahl SJ; Wingfield P; Maeda K; Harada S; Yoshimura K; Kosalaraksa P; Mitsuya H; Yarchoan R
    Antiviral Res; 2006 Nov; 72(2):89-99. PubMed ID: 16687179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.
    Dis Markers; 1990; 8(3):162-3. PubMed ID: 2125537
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.
    Sei S; Yang QE; O'Neill D; Yoshimura K; Nagashima K; Mitsuya H
    J Virol; 2000 May; 74(10):4621-33. PubMed ID: 10775598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p2gag peptide, AEAMSQVTNTATIM, processed from HIV-1 Pr55gag was found to be a suicide inhibitor of HIV-1 protease.
    Misumi S; Kudo A; Azuma R; Tomonaga M; Furuishi K; Shoji S
    Biochem Biophys Res Commun; 1997 Dec; 241(2):275-80. PubMed ID: 9425262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811.
    Dorfman T; Göttlinger HG
    J Virol; 1996 Sep; 70(9):5751-7. PubMed ID: 8709190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tripeptide glycyl-prolyl-glycine amide does not affect the early steps of the human immunodeficiency virus type 1 replication.
    Su J; Naghavi MH; Jejcic A; Horal P; Furuta Y; Wu YP; Li SL; Hall WW; Goobar-Larsson L; Svennerholm B; Vahlne A
    J Hum Virol; 2001; 4(1):8-15. PubMed ID: 11213934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conserved cysteines of the human immunodeficiency virus type 1 protease are involved in regulation of polyprotein processing and viral maturation of immature virions.
    Davis DA; Yusa K; Gillim LA; Newcomb FM; Mitsuya H; Yarchoan R
    J Virol; 1999 Feb; 73(2):1156-64. PubMed ID: 9882317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and characterization of a human immunodeficiency virus type 1 (HIV-1) mutant resistant to an HIV-1 protease inhibitor.
    el-Farrash MA; Kuroda MJ; Kitazaki T; Masuda T; Kato K; Hatanaka M; Harada S
    J Virol; 1994 Jan; 68(1):233-9. PubMed ID: 8254733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus type 1 Vif-derived peptides inhibit the viral protease and arrest virus production.
    Baraz L; Friedler A; Blumenzweig I; Nussinuv O; Chen N; Steinitz M; Gilon C; Kotler M
    FEBS Lett; 1998 Dec; 441(3):419-26. PubMed ID: 9891983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle.
    Lee SK; Harris J; Swanstrom R
    J Virol; 2009 Sep; 83(17):8536-43. PubMed ID: 19515760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein.
    Liu H; Wu X; Xiao H; Conway JA; Kappes JC
    J Virol; 1997 Oct; 71(10):7704-10. PubMed ID: 9311854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
    Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
    Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
    Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
    Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of human immunodeficiency virus type 1 transframe protein p6* mutations on viral protease-mediated Gag processing.
    Chiu HC; Wang FD; Chen YA; Wang CT
    J Gen Virol; 2006 Jul; 87(Pt 7):2041-2046. PubMed ID: 16760407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of inhibition of the retroviral protease by a Rous sarcoma virus peptide substrate representing the cleavage site between the gag p2 and p10 proteins.
    Cameron CE; Grinde B; Jentoft J; Leis J; Weber IT; Copeland TD; Wlodawer A
    J Biol Chem; 1992 Nov; 267(33):23735-41. PubMed ID: 1331099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.